IL7R and neoplasm: In contrast to the 100% protection in WT mice, combination therapy failed to cure Il7r−/− tumour-bearing mice, which rapidly died within 20 days post-tumour inoculation (Fig. 5f), reflecting a critical role of IL-7-IL-7Rα signalling in combination therapy.